What is Ironwood Pharmaceuticals's debt, current?

Ironwood Pharmaceuticals (IRWD) reported debt, current of $199.86M in Q1 2026.

What is the long-term trend for Ironwood Pharmaceuticals's debt, current?

Over 2 years (2021 to 2025), Ironwood Pharmaceuticals's debt, current has grown at a 30.7% compound annual growth rate (CAGR), from $116.86M to $199.68M.

Ironwood Pharmaceuticals IRWD Debt, current

Debt, current at other companies

Ionis PharmaceuticalsIONS

——

Other financials

Income statement

See full

Revenue$106.5M+159%

Operating income$72.6M+349%

Net income$40.8M+209%

EPS (diluted)$0.24+204%

Balance sheet

See full

Cash & equivalents$220.5M+103%

Total debt$212.4M+1,323%

Total equity-$217.1M+35.0%

Total assets$434.6M+32.8%

Cash flow

See full

Operating cash flow$5.1M-74.3%

CapEx-—

Free cash flow$74.6M+390%

Valuation

See full

Market cap$632.12M+457%

Enterprise value$624M+3,024%

P/E6.2×—

P/S1.8×+1.4×

Profitability

See full

Gross margin99.2%—

Operating margin55.4%+38.7pp

Net margin28.3%+22.3pp

FCF margin24.7%-11.1pp

Returns & leverage

See full

Return on equity29.7%-138pp

Debt / equity0×-0.5×

Current ratio1.4×-1.9×

Where this comes from

Reported directly by Ironwood Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ConvertibleDebtCurrent.

The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ironwood Pharmaceuticals's debt, current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ironwood Pharmaceuticals's debt, current?: Ironwood Pharmaceuticals (IRWD) reported debt, current of $199.86M in Q1 2026.
What is the long-term trend for Ironwood Pharmaceuticals's debt, current?: Over 2 years (2021 to 2025), Ironwood Pharmaceuticals's debt, current has grown at a 30.7% compound annual growth rate (CAGR), from $116.86M to $199.68M.